Harris Associates
GILD icon

Harris Associates’s Gilead Sciences GILD Stock Holding History

Harris Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,004
Closed -$469K – 126
2015
Q2 		$469K Sell
4,004
-7,996
-67% -$874K ﹤0.01% 130
2015
Q1 		$1.18M Buy
+12,000
New +$1.22M ﹤0.01% 138

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates's GILD Position: Q3 2015 in Review

Harris Associates sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 4,004 shares — an estimated $469K sold.

Harris Associates first reported a position in GILD in Q1 2015 and held it in 2 quarters. The position peaked at $1.18M in Q1 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Harris Associates reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Harris Associates sold 4,004 Gilead Sciences shares in Q3 2015, an estimated $469K.
  • Harris Associates first reported a position in Gilead Sciences in Q1 2015 and held it in 2 quarters.
  • Harris Associates's Gilead Sciences position peaked at $1.18M in Q1 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Harris Associates's 13F filing for Q3 2015, filed 13 Nov 2015.